Newleos Therapeutics Revenue

Biotechnology Research • 800 Boylston St, Ste. 1715, United States • 11-20 Employees

Newleos Therapeutics revenue & valuation

Annual revenue	$1,625,545
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,300,000
Total funding	$93,500,000

Key Contacts at Newleos Therapeutics

Federico Bolognani

Chief Medical Officer And Co-Founder

Ming Cheah

Member Board Of Directors

Ray Camahort

Member Board Of Directors

Tiffany Lago

Executive Medical Director

Company overview

Headquarters	800 Boylston St, Ste. 1715, Boston, Massachusetts 02199, US
Website	newleos.com
NAICS	541714
Founded	2024
Employees	11-20

Newleos Therapeutics Email Formats

Newleos Therapeutics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@newleos.com), used 64.3% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@newleos.com	64.3%
{last name}{last name}	doedoe@newleos.com	21.4%
{first name}{last name}	johndoe@newleos.com	14.3%

About Newleos Therapeutics

We are dedicated to providing a new dawn or "eos" for patients with mental health conditions by developing next generation, first- and best-in-class therapies. Over 100 million patients in the United States are affected by neuropsychiatric disorders, with anxiety and substance use disorders among the largest areas of unmet medical need. Our clinical-stage pipeline was licensed from Roche and includes oral small molecules targeting GABAA-γ1, V1a, TAAR1 and GABAA-α5 with broad potential in general anxiety, social anxiety, substance use disorders and cognitive impairment. Newleos was co-founded by Longwood Fund, Federico Bolognani, M.D., Ph.D., and William Martin, Ph.D., seasoned experts in company creation and CNS drug development.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Vice President

Director

Entry

Employees by Department

Newleos Therapeutics has 13 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Newleos Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-03-13	4	$93,500,000

Funding Insights

$93,500,000

Total funding amount

$93,500,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Newleos Therapeutics is located in 800 Boylston St, Ste. 1715, US.

Newleos Therapeutics generates an estimated annual revenue of $1,625,545. This revenue figure reflects the company's market position and business performance in its industry.

Newleos Therapeutics has an estimated valuation of $5,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Newleos Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Newleos Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Newleos Therapeutics has raised a total of $93,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Newleos Therapeutics

Federico Bolognani

Chief Medical Officer And Co-Founder

Ming Cheah

Member Board Of Directors

Ray Camahort

Member Board Of Directors

Tiffany Lago

Executive Medical Director

4.8

40,000 users